UBS raised the firm’s price target on Bruker to $102 from $94 and keeps a Buy rating on the shares. Bruker remains a top pick and UBS views the company as well-positioned on 2024 guidance and the recent pull-forward of the 2026 targets to 2025, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BRKR:
